427 related articles for article (PubMed ID: 31889409)
21. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
McCandless SE; Yanovski JA; Miller J; Fu C; Bird LM; Salehi P; Chan CL; Stafford D; Abuzzahab MJ; Viskochil D; Barlow SE; Angulo M; Myers SE; Whitman BY; Styne D; Roof E; Dykens EM; Scheimann AO; Malloy J; Zhuang D; Taylor K; Hughes TE; Kim DD; Butler MG
Diabetes Obes Metab; 2017 Dec; 19(12):1751-1761. PubMed ID: 28556449
[TBL] [Abstract][Full Text] [Related]
22. Prader-Willi syndrome, diabetes mellitus and hypogonadism.
Nagai T; Mori M
Biomed Pharmacother; 1999 Dec; 53(10):452-4. PubMed ID: 10665337
[TBL] [Abstract][Full Text] [Related]
23. Three scenarios illustrating ethical concerns when considering bariatric surgery in obese adolescents with Prader-Willi syndrome.
Di Pietro ML; Zaçe D
J Med Ethics; 2020 Nov; 46(11):738-742. PubMed ID: 32341185
[TBL] [Abstract][Full Text] [Related]
24. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
25. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
26. Obesity management in Prader-Willi syndrome.
Salehi P; Leavitt A; Beck AE; Chen ML; Roth CL
Pediatr Endocrinol Rev; 2015 Mar; 12(3):297-307. PubMed ID: 25962207
[TBL] [Abstract][Full Text] [Related]
27. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
29. Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.
Butler MG; Lee J; Cox DM; Manzardo AM; Gold JA; Miller JL; Roof E; Dykens E; Kimonis V; Driscoll DJ
Clin Pediatr (Phila); 2016 Sep; 55(10):957-74. PubMed ID: 26842920
[TBL] [Abstract][Full Text] [Related]
30. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
[TBL] [Abstract][Full Text] [Related]
31. Caregiver priorities for endpoints to evaluate treatments for Prader-Willi syndrome: a best-worst scaling.
Tsai JH; Scheimann AO; McCandless SE; Strong TV; Bridges JFP
J Med Econ; 2018 Dec; 21(12):1230-1237. PubMed ID: 30256699
[TBL] [Abstract][Full Text] [Related]
32. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
33. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
34. Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
[TBL] [Abstract][Full Text] [Related]
35. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up.
Schmidt H; Pozza SB; Bonfig W; Schwarz HP; Dokoupil K
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):651-5. PubMed ID: 18780599
[TBL] [Abstract][Full Text] [Related]
36. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome.
Gumus Balikcioglu P; Balikcioglu M; Muehlbauer MJ; Purnell JQ; Broadhurst D; Freemark M; Haqq AM
J Clin Endocrinol Metab; 2015 Oct; 100(10):3822-31. PubMed ID: 26259133
[TBL] [Abstract][Full Text] [Related]
37. Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity: Associations with weight, BMI-z, and HOMA-IR.
Orsso CE; Butler AA; Muehlbauer MJ; Cui HN; Rubin DA; Pakseresht M; Butler MG; Prado CM; Freemark M; Haqq AM
Pediatr Obes; 2019 May; 14(5):e12493. PubMed ID: 30589518
[TBL] [Abstract][Full Text] [Related]
38. Assessment of hyperphagia in Prader-Willi syndrome.
Dykens EM; Maxwell MA; Pantino E; Kossler R; Roof E
Obesity (Silver Spring); 2007 Jul; 15(7):1816-26. PubMed ID: 17636101
[TBL] [Abstract][Full Text] [Related]
39. A review of chemosensory perceptions, food preferences and food-related behaviours in subjects with Prader-Willi Syndrome.
Martínez Michel L; Haqq AM; Wismer WV
Appetite; 2016 Apr; 99():17-24. PubMed ID: 26713776
[TBL] [Abstract][Full Text] [Related]
40. Critical review of bariatric surgical outcomes in patients with Prader-Willi syndrome and other hyperphagic disorders.
Gantz MG; Driscoll DJ; Miller JL; Duis JB; Butler MG; Gourash L; Forster J; Scheimann AO
Obesity (Silver Spring); 2022 May; 30(5):973-981. PubMed ID: 35416416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
